Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
Annals of Neurology|July 1, 1981
Computed tomography in the diagnosis of Canavan's diseaseA R Rushton, B A Shaywitz, C C Duncan, et al.Neurology|March 1, 1985
Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspectiveJ F Leckman, J Detlor, D F Harcherik, et al.Advances in Neurology|January 1, 1982
Clonidine in the treatment of Tourette syndrome: a review of dataJ F Leckman, D J Cohen, J Detlor, et al.Epilepsia|March 1, 1995
Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individualsA J Rowan, B A Shaywitz, L Tuchman, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1983
Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing ratL A Raskin, B A Shaywitz, G M Anderson, et al.Psychopharmacology|January 1, 1984
Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pupB A Shaywitz, M H Teicher, D J Cohen, et al.Biological Psychiatry|January 1, 1986
Cerebrospinal fluid monoamine precursor and metabolite levels in children treated for leukemia: age and sex effects and individual variabilityM A Riddle, G M Anderson, S McIntosh, et al.Journal of Learning Disabilities|June 1, 1989
Comparisons of cutoff and regression-based definitions of reading disabilitiesJ M Fletcher, K A Espy, D J Francis, et al.Developmental Psychobiology|March 1, 1987
Amphetamine reverses learning deficits in 6-hydroxydopamine-treated rat pupsR S Wool, D A Weldon, B A Shaywitz, et al.Archives of General Psychiatry|June 1, 1980
CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspectiveJ F Leckman, D J Cohen, B A Shaywitz, et al.Pageof 12